Adagene

ADAGNasdaq China Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$271.472 M

$4.11 -0.72%

Close of 7 Aug 2026

Revenue

$7.67M

#3223 by revenue

Earnings

-$17.6M

Loss-making

Shares outstanding

59,231,993

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#244Alx OncologyALXO$282.6M
#245Veraxa BiotechVRXA$281.4M
#246AdageneADAG$271.5M
#247Entrada TherapeuticsTRDA$267.5M
#248Camp4 TherapeuticsCAMP$265.9M

Where these numbers come from

Share counts and financials for Adagene are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.